🇺🇸 FDA
Patent

US 10246514

Single domain antibodies that bind to human CD20

granted A61KA61K2039/505A61K38/177

Quick answer

US patent 10246514 (Single domain antibodies that bind to human CD20) held by United States of America as represented by the Secretary of the Air Force expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K38/177, A61K39/39533